MDGL vs. THC

In the year-to-date period, MDGL achieves a 33.30% return, which is significantly lower than THC's 71.31% return. Over the past 10 years, MDGL has outperformed THC with an annualized return of 12.97%, while THC has yielded a comparatively lower 9.48% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Madrigal Pharmaceuticals, Inc. (MDGL) and Tenet Healthcare Corporation (THC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current MDGL Sharpe Ratio is 0.61, which is lower than the THC Sharpe Ratio of 1.99. The chart below compares the historical Sharpe Ratios of MDGL and THC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither MDGL nor THC has paid dividends to shareholders.

The maximum MDGL drawdown since its inception was -98.40%, roughly equal to the maximum THC drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for MDGL and THC. For additional features, visit the drawdowns tool.

Madrigal Pharmaceuticals, Inc. (MDGL) has a higher volatility of 11.87% compared to Tenet Healthcare Corporation (THC) at 8.30%. This indicates that MDGL's price experiences larger fluctuations and is considered to be riskier than THC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Madrigal Pharmaceuticals, Inc. and Tenet Healthcare Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.